Covid-19 treatment trial for kidney patients goes national

An Addenbrooke’s trial is rolling out to hospitals across the UK to see if a drug used to treat tapeworm can give high-risk kidney patients extra protection against Covid-19.…

The PROTECT-V trial investigating UNIONs COVID-19 candidate receives Urgent Public Health…

UNION therapeutics A/S (UNION) today announced that the National Institute for Health Research (NIHR) in the UK has granted Urgent Public Health (UPH) prioritization to the …

Trials to find preventative COVID-19 treatments for most vulnerable to launch in UK

Two new clinical trials to develop treatments to prevent people catching (coronavirus) COVID-19 are to launch in the UK.

Dr Rona Smith leads Covid trial starting with tapeworm drug

Cambridge University Hospitals NHS Foundation Trust is leading a major new trial to discover whether a drug used to treat tapeworms can prevent high risk kidney patients…

Dex-CSDH study outcomes published in the New England Journal of Medicine

Outcomes of a trial of Dexamethasone for Chronic Subdural Hematoma has been published in the …

CAMPROBE study reveals differences in patterns of prostate cancer treatment in England

There are widespread differences in the way hospitals across the country treat men with prostate cancer.

Summary of TACTIC-E protocol published by BMC

A structured summary of a study protocol for a randomised controlled trial of Repurposed immunomodulatory drugs for Covid-19 in pre-ICu patients - muLTi-Arm Therapeutic study…

Cancer patients could benefit from world class web tool

Research using a sophisticated web tool, which is being carried out with help from doctors and patients at Addenbrooke’s Hospital, could lead to cancer patients receiving…

Summary of TACTIC-R protocol published by BMC

A structured summary of a study protocol for a randomised controlled trial of Repurposed immunomodulatory drugs for Covid-19 in pre-ICu patients - mulTi-Arm Therapeutic study…

Cambridge University Hospitals group launches experimental drug trial to treat Covid-19

Cambridge University Hospitals group is launching a fast-turnaround experimental drug trial to treat Covid-19.

COVID-19 research taking place at CUH

Latest update from Professor John Bradley, Director of the NIHR Cambridge Biomedical Research Centre on COVID-19 research at Cambridge University Hospitals.

New trial seeks to improve survival rates for patients with COVID-19

A new trial is taking place at Addenbrooke’s Hospital to test whether COVID-19 patients with weak immune systems have a better chance of survival if they are injected with…

Rapid coronavirus test speeds up access to urgent care

Cambridge university researchers have analysed the impact of using point-of-care testing at Addenbrooke's hospital.

Cambridge study to trial widely used drug to protect healthcare staff from COVID-19

The PROLIFIC study (ChemoPROphyLaxIs For covId-19 infeCtious disease) aims to determine whether hydroxychloroquine (HCQ), a widely used anti-malarial drug, is effective at…

Trial launched testing existing drugs in bid to treat coronavirus patients

Treating Covid-19 patients may change after a nationwide trial has…

National trial launched to find Covid-19 treatment

A new trial to prevent organ failure and death in Covid-19 patients is being launched led by clinicians and scientists in Cambridge, and at King’s College London.

Over 150 participants recruited to new COVID-19 research programme

A “library” of valuable biological samples from people with COVID-19, which will help scientists globally fight the virus, has recruited its 150th participant.

Genetic analysis reveals new causes of Primary Immunodeficiency (PID)

A UK-wide research collaboration through the NIHR BioResource for Rare Diseases has combined whole genome sequencing with a statistical program called BeviMed to predict the…

Protocol of CLOuD of published in the BMJ

A research protocol for a randomised parallel study assessing the effect of closed-loop insulin delivery from onset of type 1 diabetes in youth on residual beta-cell function…

Research staff begin working on new COVID-19 study

Research staff from NIHR Cambridge Clinical Research Facility (CRF) are being deployed onto the wards at Cambridge University Hospitals (CUH) to start using a new test for a…

Adapted care for cancer patients due to COVID-19

The Cancer Research UK Cambridge Centre and six other leading European cancer centres share knowledge and experiences to define new guidelines for treating cancer patients…

Rapid COVID-19 diagnostic test developed by Cambridge team to be deployed in hospitals

A new rapid diagnostic test for COVID-19, developed by a University of Cambridge spinout company and capable of diagnosing the infection in under 90 minutes, is being deployed…

First CUH patient in national Covid-19 Trial

Cambridge University Hospitals NHS Foundation Trust has today (Friday, 27 March) enrolled its first patient into a national trial aimed at identifying treatments for Covid-19…

Team effort achieves accreditation

Cambridge University Hospitals, as part of the Cancer Research UK Cambridge Centre, has achieved re-accreditation by the Organisation of European Cancer Institutes (OECI) as a…

COVID-19 research studies at CUH

In response to the COVID-19 pandemic Cambridge University Hospitals has put in place measures to help researchers and research infrastructure deliver COVID-19 studies, while…

Update on clinical research during the COVID-19 outbreak from CUH

As part of our response to COVID-19, some of our research activity will need to change. We are reviewing all of our clinical research with Cambridge University Hospitals (CUH)…

Global health worker shortage prompts partnership action

A Cambridge partnership is taking action in the face of a predicted shortfall of 18 million health workers globally in the next decade.

Findings of PEXIVAS published in the NEJM

Findings of a global trial of plasma exchange and steroid dosing in autoimmune vasculitis (PEXIVAS) have recently been …

New NIHR Cambridge BRC Director Appointed at CUH

The NIHR Cambridge Biomedical Research Centre (BRC) has announced Dr Miles Parkes will be the new director of the centre, based at Cambridge University Hospitals (CUH).

Statement on Coronavirus

Official statement on Coronavirus from the Department of Health

Protocol for Dex-CSDH published by BMC

A corrected protocol for a trial of dexamethasone for adult patients with a symptomatic chronic subdural haematoma (Dex-CSDH) has recently been…

The EudraCT Tool

The CCTU is pleased to launch the EudraCT Tool which was developed by our Lead Senior Statistician, Dr Simon Bond, in collaboration with colleagues from Birmingham, Glasgow and…

ICN Chair and Vice-Chair Elected

We are pleased to announce the appointment of the new ICN Chairperson, Thomas Hiemstra, and Vice Chair-person, Henry Yau.
 

CCTU Launches New Website

Collaboratively developed with Isle Interactive and hosted by Red Graphic

Load more